Lobbying

Praxis Precision Medicines PRAX's latest lobbying report covers Q2 2026, at $40K. The four quarters Q4 2025–Q3 2026 total $120K. Its first report covers Q1 2023; the issues it reports most are Pharmacy.

Praxis Precision MedicinesPRAX

Praxis Precision Medicines stock page

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$120K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q1 2023
The first quarter a report named it

Lobbying by quarter

Praxis Precision Medicines lobbying by quarter
Praxis Precision Medicines lobbying by quarter
QuarterAmountReports
Q1 2023$40K1
Q2 2023$40K1
Q3 2023$40K1
Q4 2023$40K1
Q1 2024$30K1
Q2 2024$30K1
Q3 2024$30K1
Q4 2024$30K1
Q1 2025$40K1
Q2 2025$40K1
Q3 2025$40K1
Q4 2025$40K1
Q1 2026$40K1
Q2 2026$40K1
Q3 2026$00

By issue

  • Pharmacy$520K · 14 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES14 reports
  • SENATE14 reports
  • Food & Drug Administration (FDA)1 reports

Firms it paid

Firm
The KPM Group DC$520K14 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
08/17for Q3Ballard PartnersUnder $5,000
07/28for Q2The KPM Group DC$40K
07/19for Q2The KPM Group DC$40K
04/20for Q1The KPM Group DC$40K
01/14for Q4 2025The KPM Group DC$40K
25/10/07for Q3 2025The KPM Group DC$40K
25/07/17for Q2 2025The KPM Group DC$40K
25/04/21for Q1 2025The KPM Group DC$40K
25/01/21for Q4 2024The KPM Group DC$30K
24/10/21for Q3 2024The KPM Group DC$30K
24/09/17for Q3 2023The KPM Group DC$40K
24/07/19for Q2 2024The KPM Group DC$30K
24/04/19for Q1 2024The KPM Group DC$30K
24/01/22for Q4 2023The KPM Group DC$40K
23/10/20for Q3 2023The KPM Group DC$40K
23/07/19for Q2 2023The KPM Group DC$40K
23/04/20for Q1 2023The KPM Group DC$40K
23/02/15for Q1 2023The KPM Group DCUnder $5,000